Prevention of propofol injection pain in patients using transdermal nitroglycerine

Basit Öğe Kaydı
dc.authorscopusid7004533485
dc.authorscopusid7003311524
dc.authorscopusid7003369853
dc.authorscopusid6701467427
dc.contributor.authorTuran A.
dc.contributor.authorKaramanlio?lu B.
dc.contributor.authorMemiş D.
dc.contributor.authorPamukçu Z.
dc.date.accessioned2024-06-12T10:28:19Z
dc.date.available2024-06-12T10:28:19Z
dc.date.issued2002
dc.description.abstractIn our study, we aimed to compare two different dosages of transdermal nitroglycerine with placebo in prevention of propofol injection pain. 150 patients from ASA II class who were to undergo various elective operations and who use transdermal nitroglycerine were assigned randomly in to three groups. In Gronp I pre-emptied transdermal nitroglycerine tape, in Group II transdermal nitroglycerine TTS 5 tape and in Group III transdermal nitroglycerine TTS 10 tape was applied 2 hours before the propofol injection, over the dorsum of the hand at the tip of intravenous cannula. After application of first 5 mL of propofol with a speed of 10 mg/5 sec, patients reaction and side effects were assessed. There was no propofol injection pain in 58% of group II patients and in 64% of group III patients, while different degrees of pain was seen in all the patients in placebo group. In 2% of group III patients and 10% of group II patients moderate to severe pain was seen, while moderate to severe pain was seen in 96% of patients in placebo group. There was no statistical difference between TNG- TTS 5 and TNG- TTS 10 dosages in reducing propofol pain, when compared with placebo significant difference was found. Propofol injection pain in patients using transdermal nitroglycerine used patients was significantly reduced when compared with placebo. Transdermal nitroglycerine can be useful in preventing propofol injection pain.en_US
dc.identifier.endpage155en_US
dc.identifier.issn1016-5150
dc.identifier.issue4en_US
dc.identifier.scopus2-s2.0-18344418101en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage152en_US
dc.identifier.urihttps://hdl.handle.net/20.500.14551/17171
dc.identifier.volume30en_US
dc.indekslendigikaynakScopusen_US
dc.language.isotren_US
dc.relation.ispartofTurk Anesteziyoloji ve Reanimasyonen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectPropofol Injection Pain; Transdermal Nitroglycerinen_US
dc.subjectGlyceryl Trinitrate; Placebo; Propofol; Article; Clinical Trial; Controlled Clinical Trial; Controlled Study; Dose Response; Drug Efficacy; Female; Human; Injection Pain; Major Clinical Study; Male; Pain Assessment; Randomized Controlled Trial; Side Effect; Statistical Analysis; Treatment Outcomeen_US
dc.titlePrevention of propofol injection pain in patients using transdermal nitroglycerineen_US
dc.title.alternativeTransdermal nitrogliserin kullanan hastalarda propofol enjeksiyon a?risinin önlenmesien_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu